The baffling question: why does prostate cancer relapse quickly in some patients while stabilising in others? Recent ...

Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

Prostate cancer is the second most common cancer diagnosis in men. 1 in 8 men will be diagnosed with the disease during their ...

Prostate cancer is among the most common types of cancer found in men. It develops in the prostate gland, a small organ ...

MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that it has dosed the first patient in a Phase 1 ...

Perimenopausal women who used estrogen for at least 10 years before their periods stopped had 60% lower odds for breast ...

In hormone-sensitive prostate cancer, an alternative dosing of docetaxel plus Nubeqa and ADT was associated with improvements in side effect rates.

McGeechan shared his diagnosis in May and underwent treatment, which included a six-week course of radiotherapy ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Former President Joe Biden completed a round of radiation therapy at a Penn Medicine cancer center in Philadelphia Monday as ...

Biden's daughter posted an Instagram video of her father at Penn Medicine ringing a bell, which is done to mark the end of a ...